《大行報告》大和下調李寧(02331.HK)目標價至55元 評級「買入」
大和發表研究報告指,李寧(02331.HK)上半年業績較預期好,收入按年增13%至140億元人民幣,淨利潤跌3%至21億元人民幣。李寧管理層維持2023財年收入和淨利潤率均按年增長中雙位數的指引,該行認為是一個輕微的正面因素。不過,由於消費者信心不理想、去庫存壓力於下半年持續及面對國際運動品牌的挑戰,故短期而言公司重估的催化劑有限。
該行下調集團的2023至25年每股盈測7%至11%,以反映本年至今較預期弱的消費情緒及較低的毛利率預期,目標價由74元下調至55元,惟重申「買入」評級。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.